CCMH
MYGN icon

Cornerstone Capital Management Holdings’s Myriad Genetics MYGN Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$943K Sell
27,502
-2,800
-9% -$94.5K 0.01% 908
2017
Q3 		$1.09M Sell
30,302
-4,800
-14% -$137K 0.01% 911
2017
Q2 		$906K Sell
35,102
-1,194
-3% -$25.3K 0.01% 930
2017
Q1 		$696K Sell
36,296
-109,504
-75% -$1.94M 0.01% 996
2016
Q4 		$2.43M Buy
145,800
+500
+0.3% +$9.05K 0.02% 683
2016
Q3 		$2.99M Sell
145,300
-33,100
-19% -$840K 0.02% 624
2016
Q2 		$5.46M Buy
178,400
+159,800
+859% +$5.55M 0.04% 427
2016
Q1 		$696K Buy
18,600
+2,800
+18% +$106K 0.01% 971
2015
Q4 		$682K Sell
15,800
-78,300
-83% -$3.31M 0.01% 978
2015
Q3 		$3.53M Sell
94,100
-203,570
-68% -$7.22M 0.03% 530
2015
Q2 		$10.1M Sell
297,670
-40,504
-12% -$1.38M 0.09% 260
2015
Q1 		$12M Buy
338,174
+1,084
+0.3% +$38.8K 0.11% 225
2014
Q4 		$11.5M Buy
337,090
+97,056
+40% +$3.44M 0.12% 240
2014
Q3 		$9.26M Buy
240,034
+155,579
+184% +$5.8M 0.1% 272
2014
Q2 		$3.29M Buy
84,455
+32,531
+63% +$1.21M 0.04% 530
2014
Q1 		$1.77M Buy
+51,924
New +$1.61M 0.02% 735
2013
Q4 		– Sell
-27,890
Closed -$655K – 1306
2013
Q3 		$655K Sell
27,890
-84,220
-75% -$2.39M 0.01% 898
2013
Q2 		$3.01M Buy
+112,110
New +$3.25M 0.04% 540

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cornerstone Capital Management Holdings's MYGN Position: Q4 2017 in Review

Cornerstone Capital Management Holdings reduced its Myriad Genetics (MYGN) stake by 9.2% in Q4 2017, selling an estimated $94.5K and leaving 27,502 shares worth $943K. The position accounts for 0.01% of the portfolio, ranked #908.

Cornerstone Capital Management Holdings first reported a position in MYGN in Q2 2013 and has held it in 18 quarters since. The position peaked at $12M in Q1 2015. 250 funds tracked by Wall St. Rank hold MYGN as of Q4 2017.

  • Cornerstone Capital Management Holdings held 27,502 shares of Myriad Genetics worth $943K as of Q4 2017.
  • Cornerstone Capital Management Holdings sold 2,800 Myriad Genetics shares in Q4 2017, an estimated $94.5K.
  • Myriad Genetics made up 0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #908 holding.
  • Cornerstone Capital Management Holdings first reported a position in Myriad Genetics in Q2 2013 and has held it in 18 quarters since.
  • Cornerstone Capital Management Holdings's Myriad Genetics position peaked at $12M in Q1 2015.
  • 250 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.